Synthetic Biologics, Inc. Business Operations Contracts & Agreements
12 Contracts & Agreements
- Advisory Agreements (1 contract)
- Agency Agreements (1)
- Collaboration Agreements (5)
- Sales Agreements (4)
- Termination Agreements (1)
- Collaboration Agreement to Conduct a Clinical Trial and Grant Operating License Agreement between Hospital Sant Joan Dee Deu and VCN Biosciences, S.L dated February 15, 2016 (Filed With SEC on March 16, 2022)
- Amendment No. 1, dated May 3, 2021, to the Amended and Restated At Market Issuance Sales Agreement by and among Synthetic Biologics, Inc., B. Riley Securities, Inc. and... (Filed With SEC on May 3, 2021)
- Amended and Restated At Market Issuance Sales Agreement by and among Synthetic Biologics, Inc., B. Riley Securities, Inc. and A.G.P./Alliance Global Partners, dated February 9,... (Filed With SEC on February 10, 2021)
- Termination of Exclusive License Agreement, effective November 9, 2020, by and among Cedars- Sinai Medical Center, Synthetic Biologics, Inc. and Synthetic Biomics, Inc (Filed With SEC on November 10, 2020)
- Warrant Agency Agreement, dated October 15, 2018, by and between Synthetic Biologics, Inc. and Corporate Stock Transfer, Inc. (including the form of warrant certificate) (Filed With SEC on October 15, 2018)
- Amendment No. 1 to At-The-Market Issuance Sales Agreement dated May 7, 2018 between Synthetic Biologics, Inc. and B. Riley FBR, Inc (Filed With SEC on May 7, 2018)
- ExclusiveChannel Collaboration Agreement (Filed With SEC on August 10, 2015)
- SYNTHETIC BIOLOGICS, INC. CONTROLLED EQUITY OFFERINGSM AmendmentNo. 1 to SALES AGREEMENT (Filed With SEC on December 13, 2013)
- ExclusiveChannel Collaboration Agreement (Filed With SEC on August 9, 2012)
- Financial Advisory Agreement Adeona Pharmaceuticals, Inc. 3930 VarsityDrive Ann Arbor, MI 48108 (Filed With SEC on March 30, 2012)
- ExclusiveChannel Collaboration Agreement (Filed With SEC on February 3, 2012)
- Exclusive Channel Collaboration Agreement (Filed With SEC on November 21, 2011)